Role of 18F-FDG PET scans in patients with Helicobacter pylori-infected gastric low-grade MALT lymphoma

Gut and Liver

Volumn 5, Issue 3, 2011, Pages 308-314

  Song, Kyung Ho ^a   Yun, Mijin ^b   Kim, Jie Hyun ^c   Yang, Woo Ick ^b   Kang, Dae Ryong ^d   Chung, Jae Bock ^b   Lee, Yong Chan ^b  

^a Konyang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Helicobacter pylori; MALT lymphoma; Positron emission tomography; Treatment failure

Indexed keywords

AMOXICILLIN; ANTINEOPLASTIC AGENT; CLARITHROMYCIN; FLUORODEOXYGLUCOSE F 18; RABEPRAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; DRUG MONITORING; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG UPTAKE; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; STOMACH BIOPSY; STOMACH LYMPHOMA; STOMACH SCINTISCANNING; TREATMENT PLANNING;

EID: 80052486168     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.3.308     Document Type: Article

References (23)

1. Suzuki H., Hibi T., Marshall B.J. Helicobacter pylori: Present status and future prospects in Japan. J Gastroenterol 2007;42:1-15. (Pubitemid 46357245)
2. Stolte M., Bayerdörffer E., Morgner A., et al. Helicobacter and gastric MALT lymphoma. Gut 2002;50 Suppl 3:III19-III24. (Pubitemid 34407452)
3. Steinbach G., Ford R., Glober G., et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: An uncontrolled trial. Ann Intern Med 1999;131:88-95. (Pubitemid 29340559)
4. Ruskoné-Fourmestraux A., Lavergne A., Aegerter P.H., et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001;48:297-303. (Pubitemid 32269554)
5. Alpen B., Neubauer A., Dierlamm J., et al. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000;95:4014-4015. (Pubitemid 30412884)
6. Fusaroli P., Buscarini E., Peyre S., et al. Interobserver agreement in staging gastric malt lymphoma by EUS. Gastrointest Endosc 2002;55:662-668. (Pubitemid 41123467)
7. Ferreri A.J., Freschi M., Dell'Oro S., Viale E., Villa E., Ponzoni M. Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol 2001;25:95-102. (Pubitemid 32001838)
8. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849.
9. Chan J.K. Gastrointestinal lymphomas: An overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol 1996;13:260-296. (Pubitemid 26399396)
10. Hsi E.D., Eisbruch A., Greenson J.K., Singleton T.P., Ross C.W., Schnitzer B. Classification of primary gastric lymphomas according to histologic features. Am J Surg Pathol 1998;22:17-27. (Pubitemid 28016748)
11. Weber W.A., Ott K., Becker K., et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-3065. (Pubitemid 32565444)
12. Kostakoglu L., Goldsmith S.J. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004;45:56-68. (Pubitemid 47611611)
13. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 2003;44:224-239.
14. Beal K.P., Yeung H.W., Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: A report of 42 cases. Ann Oncol 2005;16:473-480. (Pubitemid 40458327)
15. 18F-Fluoro- deoxyglucose positron emission tomography in lymphoma of mucosaassociated lymphoid tissue: histology makes the difference. Ann Oncol 2006;17:1761-1765.
16. 18F-FDG PET in gastric MALT lymphoma. Nucl Med Rev Cent East Eur 2006;9:37-40.
17. El-Zahabi L.M., Jamali F.R., El-Hajj I.I., et al. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication. Gastrointest Endosc 2007;65:89-96. (Pubitemid 44932160)
18. Sackmann M., Morgner A., Rudolph B., et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997;113:1087-1090. (Pubitemid 27418961)
19. Wotherspoon A.C., Doglioni C., Isaacson P.G. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology 1992;20:29-34.
20. Weber W.A., Ziegler S.I., Thödtmann R., Hanauske A.R., Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 1999;40:1771-1777. (Pubitemid 29523568)
21. Chen L.T., Lin J.T., Shyu R.Y., et al. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001;19:4245-4251.
22. Chen L.T., Lin J.T., Tai J.J., et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst 2005;97:1345-1353. (Pubitemid 41487802)
23. Makino Y., Suzuki H., Nishizawa T., et al. Ileal Mucosa-associated lymphoid tissue (MALT) lymphoma with a large-cell component that regressed spontaneously. Gut Liver 2010;4:117-121.